BioStem Technologies(BSEM)
POMPANO BEACH, FLBiotechnology
Focus: BioStem Technologies develops perinatal tissue-derived regenerative therapy products, primarily targeting chronic wound care indications like diabetic foot ulcers and venous leg ulcers. The company is publicly traded (NASDAQ: BSEM) but remains early-stage with minimal disclosed commercial scale.
Profile data last refreshed 16m ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
5+3 this month
Stable — net +3 jobs in 30d
4 added, 1 removed. Backfill posture.
Should You Work at BioStem Technologies?
AI assessmentBioStem offers high-risk, high-upside exposure to regenerative medicine for early-career professionals seeking startup equity and tissue engineering innovation, but lacks financial transparency and clinical clarity needed to assess mid-career stability.
Why Work Here
- Entry point into regenerative medicine with a validated perinatal tissue platform and expanding patent portfolio (5 wound-care and joint inflammation patents issued or allowed as of October 2026)
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Vendaje
Diabetic Foot UlcerClinical Trials (1)
NCT06150209A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje.
N/AHelp build intelligence for BioStem Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.